Qrono
Pre-clinicalQrono discovers and develops immunotherapy drug products targeting antigen presenting cells to enhance vaccines and cure autoimmune disease.
Founded
2019
Focus
Drug Delivery
About
Qrono discovers and develops immunotherapy drug products targeting antigen presenting cells to enhance vaccines and cure autoimmune disease.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile